A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: The Atherosclerosis Risk in Communities (ARIC) study

Atherosclerosis

Volumn 154, Issue 3, 2001, Pages 739-746

  Rasmussen, Mandy L ^a   Folsom, Aaron R ^a   Catellier, Diane J ^b   Tsai, Michael Y ^c   Garg, Uttam ^d   Eckfeldt, John H ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Coronary disease; Hemochromatosis; Prospective study

Indexed keywords

HIGH DENSITY LIPOPROTEIN; IRON; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON ABSORPTION; IRON METABOLISM; IRON STORAGE; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT;

COHORT STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES;

EID: 0035864617     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00623-7     Document Type: Article

References (67)

1. Iron and the sex difference in heart disease risk
2. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
3. Body iron stores and the risk of coronary heart disease
4. Low iron-binding capacity as a risk factor for myocardial infarction
5. A prospective study of plasma ferritin and risk of myocardial infarction in US physicians
6. Serum ferritin and ceruloplasmin as coronary risk factors
7. Serum ferritin and myocardial infarct
8. Body iron stores and the risk of coronary heart disease
9. Iron status and coronary heart disease: Negative findings from the NHANES I epidemiologic follow-up study
10. Iron stores are not associated with acute myocardial infarction
11. Body iron stores, dietary iron intake and coronary heart disease mortality
12. Body iron stores and mortality due to cancer and ischaemic heart disease: A 17-year follow-up study of elderly men and women
13. Serum iron and rick of fatal acute myocardial infarction
14. Iron and heart disease: The epidemiologic data
15. No association between serum ferritin and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study
16. The iron hypothesis-does iron cause atherosclerosis?
17. Effects of positive iron status at a cellular level
18. Iron status and risk of cardiovascular disease
19. Is iron sufficiency a risk factor in ischemic heart disease?
20. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
21. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
22. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
23. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
24. -. Implications for the action of endothelium-derived relaxing factor (EDRF)
25. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
26. Haemochromatosis and HLA-H
27. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England
28. A candidate gene for hemochromatosis: Frequency of the C282Y and H63D mutations
29. Correlation between genotype and phenotype in hereditary hemochromatosis: Analysis of 61 cases
30. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease
31. Hemochromatosis: A genetic defect in iron metabolism
32. Hemochromatosis: Genetics helps to define a multifactorial disease
33. Hereditary hemochromatosis: Gene discovery and its implications for population-based screening
34. Practice Guideline Development Task Force of the College of American Pathologists. Hereditary hemochromatosis
35. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
36. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study in men in eastern Finland
37. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
38. HFE gene mutations in coronary atherothrombotic disease
39. Haemochromatosis gene mutations and risk of coronary artery disease
40. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency
41. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency
42. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
43. 2+ precipitation
44. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experience
45. Robust variance estimation for the case-cohort design
46. Heterozygous hemochromatosis as a risk factor for premature myocardial infarction
47. Coronary heart disease and iron status: Meta-analysis of prospective studies
48. Evaluation of the iron status of a population
49. Hereditary hemochromatosis. Phenotypic expression of the disease
50. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
51. Relation between iron stores and non-insulin dependent diabetes in men: Case-control study
52. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene
53. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes
54. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM
55. Hereditary haemochromatosis mutations (HFE) in patients with Type II diabetes mellitus
56. Hemochromatosis and diabetes mellitus
57. Mutation analysis in hereditary hemochromatosis
58. Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis
59. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients
60. A simple genetic test identifies 90% of UK patients with haemochromatosis
61. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients
62. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression
63. A population-based study of the clinical expression of the hemochromatosis gene
64. Prevalence of the C282Y mutation in Brittany: Penetrance of genetic hemochromatosis?
65. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany
66. Global prevalence of putative haemochromatosis mutations